Jaykay Enterprises Q2 FY27 Results: Net Profit ₹8.7 Cr, Down 1.1% YoY
Jaykay Enterprises Ltd reported revenue from operations of ₹93.3 Cr (+47.9% YoY) and net profit of ₹8.7 Cr (-1.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.7 Cr · -1.1% YoY
ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
158,163 announcements
Jaykay Enterprises Ltd reported revenue from operations of ₹93.3 Cr (+47.9% YoY) and net profit of ₹8.7 Cr (-1.1% YoY) for Q2 FY27.
LAPL Automotive Ltd reported revenue from operations of ₹43.6 Cr (+4.1% YoY) and net profit of ₹3 Cr (-9.1% YoY) for H1 FY27.
H1 FY27 consolidated revenue ₹2,449.8 lakh (−21.7% YoY) as B2G winds down. Loss after minority narrowed to ₹314.9 lakh from ₹852.0 lakh. BAU EBITDA turned positive.
Anjani Foods disclosed the resignation of CFO D Venu Gopal, effective close of business on 13 November 2026, citing personal reasons. The filing is a KMP departure notice under Regulation 30.
Q2 FY27 revenue from operations ₹27,464 Mn (+17%), EBITDA ₹3,306 Mn at 12.0% margin, Adj PAT ₹1,663 Mn (+25%). Strategy: defence/aerospace pivot, CV and PV expansion, new facilities.
RHI Magnesita India announced Abhishek Bajaj's appointment as CFO and Chief Investor Relations Officer, effective January 1, 2027. He is a chartered accountant with two decades' experience.
Q2 profit rebound is largely handover-driven, but net debt rose to ₹761 Cr and FY27 needs a steep H2 ramp. The FY28 target slide was dropped, then reaffirmed without a fresh number.
Shivchem Agro Limited told BSE that its Reg 32 statement of deviation on IPO proceeds is not applicable for the half year ended September 30, 2026. The company's equity shares listed on the BSE SME Platform on October 6, 2026.
Ikoma Technologies will miss the November 14, 2026 deadline for Q2 and half-year unaudited results. It will convene a board meeting at the earliest possible date.
Orchid Pharma's QIP monitoring report for the quarter ended September 2026 shows no deviation from objects. It flags revised fund allocation and delayed Jammu facility commercial operations.
Manipal Health Enterprises submitted CARE Ratings' monitoring agency report for the quarter ended September 30, 2026. It reports nil deviation from the IPO objects.
Italian Edibles Limited's board approved unaudited half-year results for the period ended September 30, 2026, plus auditor appointments. The filing carries no monetary event value.
Hazoor Multi Projects Ltd reported revenue from operations of ₹137.9 Cr (+35.1% YoY) and net profit of ₹0.4 Cr for Q2 FY27.
Q2 revenue ₹227.6 Cr (+38.8%) with EBITDA margin up 300bps to 9.8%, but growth is mainly price-led. Management gave no numeric guidance and is cautious on gas costs and Morbi pricing.
Bhagyanagar India Limited appointed Rahul Surana as Chief Financial Officer, effective November 13, 2026. This is a senior management appointment with no associated financial value.
Asgard Alcobev Ltd reported revenue from operations of ₹48.9 Cr (+102.9% YoY) and net profit of ₹2.5 Cr (+1150.0% YoY) for Q2 FY27.
Destiny Logistics resigned its Company Secretary and Compliance Officer, Rinky Shaw, effective 13 November 2026. Kajal Sharma was appointed to the same role effective 14 November 2026.
Panafic Industrials Ltd reported revenue from operations of ₹3.2 Cr (+1500.0% YoY) and net profit of ₹4.6 Cr (+4500.0% YoY) for Q2 FY27.
Jungle Camps India won an eco-tourism operator LOA at Shali Tibba, Himachal Pradesh. Annual concession fee is ₹0.19 Crore plus taxes, escalating 3% yearly.
Apana Logistics filed its Reg 32 statement of IPO fund utilisation for the quarter ended 30 September 2026. No deviation or variation in utilisation was reported.
Q2 revenue ₹3,400 Cr (+37% YoY), EBITDA ₹882 Cr (+30%), 26% margin, volume-led. Eastern government-scheme volumes fell; Sayadri margin recovery is the main story. Management gave no EBITDA guidance.
Manilam Industries India Ltd reported revenue from operations of ₹50.4 Cr (-16.4% YoY) and net profit of ₹0.4 Cr (-87.5% YoY) for H1 FY27.
NCL Research & Financial Services filed its Reg 32 statement for the quarter ended September 30, 2026. It reports no deviation or variation in use of rights issue proceeds.
Vanta Bioscience Ltd reported revenue from operations of ₹1.1 Cr (+266.7% YoY) and net profit of ₹0.1 Cr for H1 FY27.
TAKE Limited reported consolidated Total Income of ₹615.54 Million and PAT of ₹32.75 Million for H1 FY27 in a press release. The release also highlights its return to profitability and new digital health and longevity initiatives.
Arvaya Healthcare Ltd reported revenue from operations of ₹40.3 Cr and net profit of ₹1.4 Cr for Q2 FY27.
Aarvi Encon Ltd reported revenue from operations of ₹160.5 Cr (+1.0% YoY) and net profit of ₹3.6 Cr (-25.0% YoY) for Q2 FY27.
Z-Tech filed its Reg 32 statement for the quarter ended 30.09.2026 on preferential warrant proceeds. No deviation or variation in utilisation of funds was reported.
Shivchem Agro Ltd's board appointed M/s Sonam Jeetesh Agrawal and Associates as Secretarial Auditor for FY 26-27. The appointment is a routine governance step with no financial value.
Starteck Finance Ltd reported revenue from operations of ₹10.6 Cr (+12.8% YoY) and net profit of ₹7.6 Cr (+2.7% YoY) for Q2 FY27.